New study aims to spot hidden muscle loss from popular diabetes drugs
NCT ID NCT07156331
First seen Sep 30, 2025 · Last updated May 05, 2026 · Updated 32 times
Summary
This study looks at 20 adults with type 2 diabetes who are starting drugs like semaglutide or tirzepatide. The goal is to use advanced PET/CT scans to detect early changes in muscle and bone that could lead to weakness or falls. Researchers will also test strength and mobility to help doctors identify who needs extra support like physical therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.